Cucurbita maxima trypsin inhibitor I (CMTI-I), a member of the squash-type protease inhibitor family, is composed of 29 amino acids and shows strong inhibition of trypsin by its compact structure. To study the structure-function relationship of this inhibitor using protein engineering methods, we constructed an expression system for CMTI-I as a fused protein with porcine adenylate kinase (ADK). A Met residue was introduced into the junction of ADK and CMTI-I to cleave the fusion protein with CNBr, whereas a Met at position 8 of authentic CMTI-I was replaced by Leu. Escherichia colt JM109 transformed with the constructed plasmid expressed the fused protein as an inclusion body. After cleavage of the expressed protein with CNBr, fully reduced species of CMTI-I were purified by reversed-phase HPLC and then oxidized with air by shaking. For efficient refolding of CMTI-I, we used 50 mM NH 4 HCO 3 (pH 7.8) containing 0.1% PEG 6000 at higher protein concentration. Strong inhibitory activity toward trypsin was detected only in the first of three HPLC peaks. The inhibitor constant of CMTI-I thus obtained, in which Met8 was replaced by Leu, was 1.4 X10" 10 M. The effect of replacement of Met with Leu at position 8 was shown to be small by comparison of the inhibitor constant of authentic CMTI-III bearing Lys at position 9 (8.9 XlO~n M) with that of its mutant bearing Leu at position 8 and Lys at position 9 (1.8X10-10 M). To investigate the role of the well conserved hydrophobic residues of CMTI-I in its interaction with trypsin, CMTI-I mutants in which one or all of the four hydrophobic residues were replaced by Ala were prepared. The inhibitor constants of these mutants indicated that those with single replacements were 5-40 times less effective as trypsin inhibitors and that the quadruple mutant was -450 times less effective, suggesting that the hydrophobic residues in CMTI-I contribute to its tight binding with trypsin. However, each mutant was not converted to a temporary inhibitor.
Introduction
Proteinaceous protease inhibitors exist in various microorganisms and tissues of animals and plants and inhibit the activity of proteases by forming stable complexes (Laskowski and Kato, 1980) . We have carried out studies on the structurefunction relationship of protease inhibitors using Streptomyces subtilisin inhibitor (SSI) from Streptomyces albogriseolus (Kojima et ai, 1990 (Kojima et ai, , 1993 (Kojima et ai, , 1994a Tamura et ai, 1991; Takeuchi et ai, 1992) and ovomucoid domain 3 from hen egg white (Kojima et ai, 1994b) to clarify the functional structures responsible for their action. We have also succeeded in altering their inhibitory specificity toward proteases by substitution of amino acid residues at their PI site (Kojima et ai, 1990 (Kojima et ai, ,1994b .
In the present study, a trypsin inhibitor from a member of the squash family has been used as a model protein for the study of protease inhibitors. Squash-family protease inhibitors, which are composed of about 30 amino acids and have a compact structure held together by three disulfide bridges (Wieczorek et ai, 1985; Hara et ai, 1989; Hamano et ai, 1995) , are the smallest proteins in the proteinaceous protease inhibitors, and thus are considered to be useful materials for studies of the structure-function relationship of protease inhibitors, since the number of amino acids that can be replaced is naturally limited. The structure-function relationship of squash-family inhibitors has been studied by producing several mutants of Cucurbita maxima trypsin inhibitor III (CMTI-HI) (McWherter et ai, 1989; Rolka et ai, 1991; Rozycki et ai, 1994) and Ecballium elaterium trypsin inhibitor II (EETI-H) (Favel et ai, 1989) by peptide synthesis. In addition, their short length has made it possible to generate site-specific mutants which contain non-natural amino acids by chemical synthesis (Favel et ai, 1989) . Peptide synthesis using gene engineering also has certain advantages, since the length of the resulting peptides is completely uniform, and many mutants can be made by gene engineering more easily and inexpensively than by chemical synthesis, once a corresponding gene has been constructed. Synthesis of a squash-family inhibitor by gene engineering has been reported for Trichosanthes kirilowii trypsin inhihitor I (TTI-I) (Chen et ai, 1992) . This inhibitor was synthesized as a fused protein with (i-galactosidase and its active form was obtained after cleavage with CNBr. However, no studies on site-specific mutants of TTI-I have yet been reported. In this study, therefore, we chose CMTI-I as a representative squash-family inhibitor and used the gene engineering method to prepare its mutants, since its threedimensional structure has been clarified by X-ray crystallography (Bode etai, 1989) and NMR spectroscopy (Holak etai, 1989) , thus allowing the effects of amino acid replacements on its inhibitory activity to be examined on the basis of these structures.
In this paper, we report an expression system for CMTI-I as a fused protein in Escherichia coli, its efficient refolding to an active form and the effects of substitution of the hydrophobic residues of the molecule on its inhibitory properties.
Materials and methods

Materials
Restriction enzymes and DNA-modifying enzymes were purchased from Takara Shuzo, Toyobo and Boehringer Mannheim. Trypsin (TPCK-treated) was obtained from Sigma. Other chemicals were of reagent grade for biochemical research. AATTC ATQ COT GTG TGC CCQ CGT ATC CTG CTG GAA  G TAC GCA CAC ACG GGC GCA TAG GAC GAC CTT   TGC AAG AAA GAC TCC GAC TGC CTG GCG GAA TOT GTG TGC  ACG TTC TTT CTG AGO CTG ACG QAC CGC CTT ACA CAC ACG   CTG GAA CAT GGC TAT TGT GOT TGA TA  GAC CTT GTA Nuclcotrde sequence of the synthetic gene of CMTI-I which was designed to be fused with the ADK gene. Met was introduced before the N-terminal Arg of CMTI-I, whereas Met at position 8 of authentic CMTI-I was replaced by Leu. DNA fragments between the arrow heads were synthesized, and after phosphorylation of the 5'-termini, the fragments were annealed and inserted into the fcoRI-Wndlll site of pUC18.
Authentic CMTI-III from a natural source was kindly provided by Professor Saburo Hara, Kyoto Institute of Technology.
Construction of an expression plasmid of CMTI-I as a fused protein
The CMTI-I gene was designed by choosing the favorable codons used in E.coli and synthesized chemically as eight fragments, as shown in Figure 1 . After purification by electrophoresis, their 5'-termini were phosphorylated with T4 polynucleotide kinase and ATP. Fragments corresponding to plus and minus strands of a gene were annealed by incubating at 70°C for 20 min, then at room temperature for 30 min. Four annealed fragments were mixed, and incubated at 37°C for 10 min, then at room temperature for 10 min, and at 4°C for 30 min. The CMTI-I gene thus constructed was ligated with pUC18 which had been previously digested with EcoRl and Hindlll, and transferred into E.coli. The nucleotide sequence of this synthetic CMTI-I gene was verified by dideoxy sequencing of the plasmid. A plasmid pMKAK3, which had been shown to express porcine adenylate kinase (ADK) as an inclusion body (Kumagai et al., 1990) , was digested with Smal whose recognition site is located in the middle of the ADK gene. The cohesive ends of the CMTI-I gene produced by digestion with EcoRl and Hindlll were converted to blunt ends using Klenow fragment and deoxyribonucleotides, and ligated with the digested pMKAK3. An expression plasmid in which the CMTI-I gene was fused with the ADK gene in a correct orientation was screened by colony hybridization using an oligonucleotides with a sequence of 5' GCTACCCCCAATTCATGC 3' as a probe. The expression plasmid of CMTI-I thus constructed was named pMKAKCM.
Expression and purification of the fused protein Escherichia coli JM109, transformed with the plasmid pMKAKCM, was grown in LB medium overnight and then suspended in 10 mM Tris-HCl, 1 mM EDTA (pH 8.0) after harvesting. The suspension was sonicated and centrifuged at 10 000 g for 10 min, then the inclusion bodies collected as a pellet were dissolved in 8 M urea, 0.1 M Tris-HCl (pH 8.0) and precipitated with trichloroacetic acid at a final concentration of 20% to remove low molecular weight materials.
Cleavage with CNBr and purification of the reduced species of CMTI-I
The fused protein (~10 mg) isolated from 100 ml of culture was dissolved in 4 ml of 70% formic acid, to which 80 mg of CNBr (2%) and 40 ^1 of P-mercaptoethanol (1%) were added, and left at 37°C for 24 h. After confirming the cleavage of the fused protein by SDS-PAGE, the reaction mixture was dialyzed against water and lyophilized. The cleaved sample was dissolved in 6 M guanidine hydrochloride, 0.5 M TrisHCl, 10 mM EDTA (pH 8.5). Reduction of cystine residues was carried out with dithiothreitol (20-fold molar excess relative to the cystine residues) at 37°C for 2 h under nitrogen. The reaction mixture was treated with 0.1% trifluoroacetic acid and subjected to reversed-phase HPLC on a C 4 column (Asahipak C4P-50, 150X4.6 mm i.d.) in 0.1% trifluoroacetic acid with an acetonitrile gradient.
Oxidation of the reduced form of CMTI-I and isolation of an active species
After lyophilization, the fully reduced form of CMTI-I was dissolved in 50 mM NH 4 HCO 3 (pH 7.8) at a concentration of 500 |iM, and the mixture was shaken at 37°C overnight to oxidize cysteine residues of CMTI-I with air. After lyophilization, the reaction mixture was dissolved in 0.1% trifluoroacetic acid and subjected to reversed-phase HPLC on a C 4 column as described above.
Site-directed mutagenesis
The £coRl-/Y/>idIII fragment of a synthetic gene of CMTI-I was inserted into the EcoRl-Hindlll site of pTZl9U and the constructed plasmid was transferred into E.coli CJ236. The single-stranded DNA containing urasil bases was prepared by infection of helper phage M13KO7 and site-directed mutagenesis was carried out using oligonucleotides as mutation primers according to the method of Kunkel (1985) . The primers used were 5' GT-GTG-TGC-G*CG-CGT-ATC 3' for Pro4 -> Ala, 5' C-CCG-CGT-G*C*C-CTG-CTG 3' for Ile6 -> Ala, 5' GT-ATC-CTG-G*C*G-GAA-TGC-A 3' for Leu8 -> Ala, 5' C-GAC-TGC-G*C*G-GCG-GAA-T 3' for Leu 17 -> Ala and 5'ATC-CTG-CTG-A*AA-TGC-AAG-AA 3' for Glu9 -> Lys, where the asterisk indicates a mismatched base. A mutated gene encoding a mutant CMTI-I in which all the four residues (Pro4, Ile6, Leu8 and Leu 17) were substituted with Ala residues was constructed from newly synthesized oligonucleotides by the same procedures as described for the wild type. The Ala codons in this quadruple mutant were the same as those for the single-substitution mutants: GCG at positions 4, 8 and 17 and GCC at position 6. The mutations were confirmed by dideoxy sequencing of the plasmids and the mutated genes were inserted into the Smal site of plasmid pMKAK3.
Estimation of inhibitor concentration
The molar concentration of inhibitors was determined from the absorbance at 280 nm and the molar absorption coefficient of 1250, since the inhibitors have one Tyr residue, and was also confirmed by the modified method of Lowry (Bensadoun and Weinstein, 1976) using authentic CMTI-III as a standard protein.
Determination of the inhibitor constant (K,) for trypsin
Trypsin (2 yig, 85.8 pmol) and various amounts of inhibitors were incubated in 0.2 ml of 0.1 M Tris-HCl (pH 7.8) at 25°C for more than 20 min. To this mixture, 0.8 ml of 0.231 mM benzoyl-L-Arg p-nitroanilide in the buffer was added, and the 20 Time(min) Fig. 2 . Reversed-phase HPLC for purifying the reduced species of CMTI-I(M8L). The cleaved sample was reduced with dithiothreitol and subjected to reversed-phase HPLC on a C 4 column (Asahipak C4P-50, 150X4.6 mm i.d.). After washing with 0.1% tnfluoroacetic acid for 5 min, a gradient of acetonitrile in 0.1% tnfluoroacetic acid was started. The peak indicated by the arrow was found to correspond to a reduced form of CMTI-I(M8L) by amino acid sequencing and composition analysis. If necessary, to improve the purity, the collected samples were lyophilized and subjected to reversedphase HPLC again.
increase in absorbance at 410 nm was monitored at 25°C. From the resulting kinetics, the K x value was calculated using the same procedures as those described previously (Kojima et al, 1994a,b) with a substrate K m value of 0.38 mM; Measurements of circular dichroism (CD) spectra CD spectra of inhibitors in 10 mM borate, 0.1 M KC1 (pH 8.0) were measured with a JASCO-J720 circular dichroism spectrophotometer. The temperature was regulated by circulation of electrostatically controlled water through a jacket surrounding the cell.
Results and discussion
Construction of an expression system for CMTI-I Initially, we attempted to express CMTI-I in E.coli as a secretory protein using a signal peptide of alkaline phosphatase, which has been utilized in our laboratory for efficient secretory production of ovomucoid domain 3 (Kojima et al, 1994b) , a protease inhibitor with about 60 amino acids from egg white. A gene encoding the signal peptide and CMTI-I was synthesized chemically and placed downstream from the tac promoter in the high-copy plasmid pMK2 (Kaji et al., 1989) . However, secretory expression of CMTI-I after induction by IPTG was not detected by electrophoretic and HPLC analyses (data not shown), possibly owing to degradation of CMTI-I by proteases of E.coli, even though CMTI-I is a protease inhibitor. Difficulty with the direct production of small peptides from corresponding genes without fusion with a larger protein has been reported for other small peptides (Taniguchi et al, 1980; Gan et al., 1989) .
We then attempted to express CMTI-I as a fused protein with porcine adenylate kinase (ADK), which had been shown to be expressed as an inclusion body (Kumagai et al., 1990) . In our laboratory, this expression system has been used to produce a 21-residue peptide considered to form an a-helix (Kojima et al, 1996) . A Met residue was introduced into the junction between ADK and CMTI-I, allowing the fused protein to be cleaved by CNBr. The Met residue at position 8 of authentic CMTI-I was thus replaced by a Leu residue. The fused protein, expressed as an inclusion body, was treated with CNBr in 70% formic acid to separate CMTI-I(M8L) from the ADK portion, and fully reduced species of CMTI-I(M8L) was purified by reversed-phase HPLC, as shown in Figure 2 . Amino After lyophilization, each sample was dissolved in 0.1% trifluoroacetic acid and subjected to reversed-phase HPLC on a C 4 column, as described in Figure 2 . PEG 6000 in the buffer was found to elute at 29 mm, when monitored by the absorbance at 230 nm.
acid sequencing and composition analysis confirmed the correct production of CMTI-I(M8L) (data not shown).
Folding of CMTI-I to an active form
The reduced CMTI-I(M8L) (abbreviated as CMTT-I in this section) was oxidized by air by shaking in 50 mM Tris-HCl (pH 8.0) at a protein concentration of 50 u,M, and subjected directly to reversed-phase HPLC to isolate a refolded active species, since authentic CMTI-I has been shown to be very stable (Wieczorek et al., 1985) . As shown in Figure 3A , three peaks were observed. Strong inhibitory activity toward trypsin was detected only in the first of these peaks. Since authentic CMTI-III, in which the amino acid at position 9 (Lys) differs from that of CMTI-I (Glu), was available from Japanese pumpkin seeds, the CD spectra of the molecules derived from the three peaks and authentic CMTI-III were compared. As shown in Figure 4 , the CD spectrum of the molecule from the first peak was almost the same as that of authentic CMTI-III, but clearly different from that of the molecule from the second or third peak, and therefore we concluded that the active species in the first peak was a properly folded form of CMTI-I.
Initially, the reduced CMTI-I was oxidized in 50 mM TrisHCl (pH 8.0) at a protein concentration of 50 uM, as described above. However, both the yield calculated from the amount of injected sample and the ratio of the active form (first peak) to other forms (second and third peaks) were low, possibly owing to aggregation or adsorption of the refolding molecule of CMTI-I to the vessel wall and inadequacy of the buffer used for refolding. The yield was improved by addition of 0.1% polyethylene glycol 6000 (PEG 6000), which prevents aggregation or adsorption ( Figure 3B ), and the ratio of the active peak was improved by use of NH4HCO3, which had been used previously for the refolding of EETI-II (Le-Nguyen et al, 1993) , as a buffer for refolding ( Figure 3C ). In addition, CMTI-I refolded to an active form more efficiently under a high protein concentration than under a low concentration, as shown in Figure 5 . Since the ratio of the active relative to inactive species seemed to be affected by the buffer used for refolding, we examined the effects of various types of buffer containing 0.1% PEG 6000 at pH 7.8 on the refolding efficiency of CMTI-I. The elution patterns for sodium hydrogen carbonate, ammonium chloride, sodium phosphate and ammonium hydro- gen carbonate were as shown in Figure 6A , that for sodium acetate in Figure 6B and those for HEPES, TES and Tris in Figure 6C . Sodium acetate buffer was the most effective for refolding, and Good's buffers were less effective. Efficient refolding in sodium acetate buffer was considered to be due to the acetate ion, because refolding in sodium acetate was more efficient than in sodium hydrogen carbonate or sodium phosphate. A similar effect of sodium acetate on protein folding has been reported for a mature form of subtilisin BPN' (Matsubara et al., 1994) , whose refolding had been considered difficult in the absence of pro-peptide (Shinde and Inouye, 1993) . Although the hydrophobic moieties of the acetate ion may be important, the refolding efficiency of CMTI-I in Good's buffers, which also possess hydrophobic moieties, was lower than that in acetate or inorganic salts. The hydrophobic moieties of acetate may contribute to formation of the environments required for efficient protein folding to a greater extent than the others do. In subsequent experiments, ammonium hydrogencarbonate buffer was used for refolding of CMTI-I and its mutant forms, since the action of sodium acetate as a buffer is weak at pH 7.8 because of its pK a value of 4.8.
To investigate the nature of the molecular species derived from the second and third peaks detected on reversed-phase HPLC, i.e. to clarify whether they are folding intermediates or misfolded species, each peak was lyophilized and shaken in the buffer again. The reversed-phase HPLC elution pattern of the reaction mixture from each peak after prolonged incubation did not change, whereas re-oxidation of the reduced species of CMTI-I derived from the second or third peak produced a properly folded species (data not shown). In addition, free thiols were not detected for either species in guanidium chloride solution by Ellman's method (Ellman, 1959) . Molecular species in the second and third peaks may thus be misfolded species with three disulfide bridges that are different from those in wild-type CMTI-I. This appears to be supported by the fact that the CD spectra of these species are different from those of wild-type CMTI-III and refolded CMTI-I in the first peak, as shown in Figure 4 . The inhibitor constant toward trypsin of active CMTI-I(M8L), eluted as the first peak on reversed-phase HPLC, was determined to be 1.4X10" 10 M using a synthetic substrate. In this study, since the Met residue at position 8 of authentic CMTI-I was replaced by a Leu residue to allow cleavage of the fusion protein by CNBr, the effect of this replacement on the interaction with trypsin was examined. Authentic CMTI-I was not available from its natural source, Japanese pumpkin seeds, because of its extremely low amounts, whereas authentic CMTI-III, in which the Glu residue at position 9 of CMTI-I was replaced by Lys, was available. Therefore, a CMTI-III mutant with a Leu residue at position 8 was made by mutation of the CMTI-I gene, and its inhibitor constant for trypsin was determined to be 1.8X10-'° M. This value was close to that of authentic , showing that the effect of Met to Leu replacement at position 8 was small in CMTI-III.
From the crystal structure of CMTI-I, the role of the Met residue at position 8 has been considered to be formation of a hydrophobic surface along with the side chains of Pro4, Ile6 and Leu 17 to prevent three water molecules from diffusing into the solvent (Bode et al., 1989) . Therefore, a Leu residue, possessing hydrophobic moieties, would have been able to substitute the role of the Met residue in CMTI-III. Similarly, the replacement of Met with Leu at position 8 would exert only minor effects on the inhibitory activity of CMTI-I, since CMTI-I and CMTI-III differ in only one amino acid residue at position 9. Therefore, CMTI-I(M8L) was used as a standard protein in subsequent mutagenesis studies. The inhibitor constants of authentic CMTI-I and CMTI-III from the natural source were also determined to be 3.1 X10~1 2 M and 1.5X 10~1 2 M, respectively, by Wieczorek et al. (1985) . The difference in the values between their study and ours appears to have been due to the difference in the assay conditions employed, such as a substrate and pH of Tris buffer. Effects of replacements of hydrophobic amino acids in CMTI-I on its inhibitory activity toward trypsin CMTI-I has four hydrophobic residues (Pro4, Ile6, Met8 and Leu 17) which are well conserved among squash-family protease inhibitors ( Figure 7 ). As shown in Figure 8 and described above, they surround three water molecules which are considered to be integral constituents for maintaining the structure of the CMTI-I molecule (Bode et al., 1989) . To investigate the effects of replacements of these hydrophobic residues on the interaction of CMTI-I with trypsin, CMTI-I mutants in which one or all of the four residues was replaced with Ala were prepared. The reduced form of each CMTI-I Fig. 8 . Schematic representation of the tertiary structure of CMTI-I and three 'internal' water molecules. This figure was modified from that of Bode et aL (1989) . Side chains of Pro4, Ile6, Met8 and Leu 17 which surround the 'internal' water molecules are shown by bold lines and disulfide bridges by broken lines. 
.9X10" 9 6.4X10" 8 mutant was efficiently refolded into an active species in ammonium hydrogen carbonate buffer, as in the case of CMTI-I(M8L). The inhibitor constants of these mutants for trypsin were determined, and are summarized in Table I . The single mutants were 5-40 times less effective as trypsin inhibitors and the quadruple mutant was ~450 times less effective than CMTI-I(M8L). Thus, the hydrophobic residues of CMTI-I contribute to its tight binding with trypsin. Conformational rigidity of the main chain around the reactive site of protease inhibitors is generally required for their inhibitory action through tight binding with cognate proteases and prevention of their degradation by the proteases (Laskowski and Kato, 1980) . In protease inhibitors such as Streptomyces subtilisin inhibitor (SSI) and ovomucoid domain 3 (0VM3), conformational rigidity around the reactive site is considered to be maintained by hydrogen bonds between the main chain around the reactive site and the side chain of the Asn residue in the secondary contact region, together with a disulfide bridge near the reactive site (Kojima et al, 1993) . One of the three water molecules in CMTI-I occupies the site which is equivalent to the N82 atom of the Asn residue of SSI and 0VM3 (Bode etal, 1989) and thus, in CMTI-I, conformational rigidity of the reactive site seems to be maintained by these water molecules. Therefore, alteration of the buried water molecules to diffuse easily into the solvent by substituting the hydrophobic side chains would lead to an increase in fluctuation of the main chain around the reactive site of CMTI-I, thus reducing the interaction with trypsin. The different effect of each mutation on the inhibitor constant may be due to the difference in the resulting increase in fluctuation. Since hydrophobic residues surround the integral water molecules, the decrease in the interaction of the quadruple mutant with trypsin seems to be smaller than the sum of the decreases in the four single-replacement mutants.
Recently, we have demonstrated that replacement of the Asn residue in the secondary contact region converts SSI into a temporary inhibitor which exhibits a time-dependent decrease in inhibitory activity after mixing with protease (S.Kojima, I. Kumagai and K.Miura, in preparation) . We therefore examined the possibility of conversion of CMTI-I into a temporary inhibitor by these replacements. However, no temporary inhibition was observed in the CMTI-I mutants, including the quadruple mutant (data not shown). This may have been due to the high stability of the CMTI-I molecule in view of its compact structure maintained by three disulfide bridges among the 29 amino acid residues (Wieczorek et ai, 1985; Hara et ai, 1989) . In fact, it has been reported that bovine pancreatic trypsin inhibitor (BPTI), which is also an extremely stable molecule, could not be converted into a temporary inhibitor merely by removal of a disulfide bridge near its reactive site (Marks et ai, 1987) .
